The U.S. Army down selected Lockheed Martin’s (NYSE: LMT) Spike Non-Line-of-Sight (NLOS) system capability for Phase 2 of the Mobile-Long Range Precision Strike Missile (M-LRPSM) Directed Requirement competition. Lockheed Martin was awarded a Phase 2 contract with a total value of $30 million to continue to integrate and test the precision-guided missile system.
“Being down selected so quickly for Phase 2 of the M-LRPSM competition is a significant achievement, and we are confident our mature Spike NLOS system will meet the U.S. Army's long-range precision strike needs and provide Mobile Brigade Combat Teams with the combat agility they need to succeed in a changing battlefield,” said Casey Walsh, program director, Lockheed Martin Multi-Domain Missile Systems.
In Phase 2, Lockheed Martin will build and deliver hardware for safety confirmation testing, including installation of the Spike NLOS system onto an Infantry Utility Vehicle to demonstrate its safe and effective operation in various environments. Lockheed Martin's selection for Phase 2 follows a successful Phase 1 demo in August, where the Spike NLOS system showcased its non-line-of-sight capability by precision-engaging long-range obscured targets.
Market forecast by Region, Type, and Launch Method. Country Analysis, Market and Technology Overview, Competitive Landscape, Opportunities and Impact Analysis, and Leading Company Profiles
Download free sample pages More informationThe U.S. Army has successfully tested the Spike NLOS system in several recent live fire exercises, including with the 101st Combat Aviation Brigade within the U.S. Central Command (USCENTCOM) area of responsibility, from a U.S. Army 12th Combat Aviation Brigade AH-64Ev6 Apache Guardian helicopter in joint exercise in Poland, and by the 16th Combat Aviation Brigade at Yuma Proving Ground. The recent US Army Combat Aviation Brigade events showcased the capabilities of the Spike NLOS missile that will be used for the M-LRPSM Directed Requirement.
A final decision on the competitor selection is expected after the completion of Phase 2.